Camelliaside A

Camelliaside A

SCHEMBL13328501

CC1OC(OCC2OC(Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)C(OC3OC(CO)C(O)C(O)C3O)C(O)C2O)C(O)C(O)C1O

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P4HB P07237 6/20 0.83
▸ POLB P06746 4/20 0.83
▸ GAA P10253 4/20 0.83
▸ APEX1 P27695 3/20 0.83
▸ RECQL P46063 2/20 0.83
▸ XDH P47989 2/20 0.83
▸ L3MBTL1 Q9Y468 2/20 0.83
▸ KDM4E B2RXH2 5/20 0.83
▸ HES1 Q14469 2/20 0.74
▸ FANCF Q9NPI8 2/20 0.74
▸ MAPT P10636 3/20 0.73
▸ ACHE P22303 2/20 0.73
▸ KDM1A O60341 1/20 0.73
▸ PRSS1 P07477 1/20 0.73
▸ PRSS2 P07478 1/20 0.73
▸ ADRA2A P08913 1/20 0.73
▸ HMGB1 P09429 1/20 0.73
▸ CFTR P13569 1/20 0.73
▸ ADRA2C P18825 1/20 0.73
▸ MAOA P21397 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Camelliaside A SCHEMBL29882538 1.00 P4HB (0.83) P4HBPOLBGAAAPEX1RECQL
Camelliaside A SCHEMBL14813695 1.00 P4HB (0.83) P4HBPOLBGAAAPEX1RECQL
Camelliaside A SCHEMBL30637486 1.00 P4HB (0.83) P4HBPOLBGAAAPEX1RECQL
Mauritianin SCHEMBL18167030 0.97 P4HB (0.88) P4HBPOLBGAAAPEX1RECQL
Mauritianin SCHEMBL30003610 0.97 P4HB (0.88) P4HBPOLBGAAAPEX1RECQL
Mauritianin SCHEMBL3746601 0.97 P4HB (0.88) P4HBPOLBGAAAPEX1RECQL
Mauritianin SCHEMBL572331 0.97 P4HB (0.88) P4HBPOLBGAAAPEX1RECQL
Mauritianin SCHEMBL572330 0.97 P4HB (0.88) P4HBPOLBGAAAPEX1RECQL
SCHEMBL38650627 0.96 GAA (0.91) P4HBPOLBGAAAPEX1RECQL
SCHEMBL30870428 0.96 GAA (0.91) P4HBPOLBGAAAPEX1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024234021-A2 CONJUGATE AND COMPOSITION FOR TREATING CANCER STELLENBOSCH UNIVERSITY (ZA) 2024-11-14 — — WO disclosed
US-20100113372-A1 Method For Preparing Kaempferol-3-0-Rutinoside and Composition of Skin External Application Comprising Thereof AMOREPACIFIC CORPORATION (KR) 2010-05-06 — — US disclosed
US-20100113372-A1 Method For Preparing Kaempferol-3-0-Rutinoside and Composition of Skin External Application Comprising Thereof AMOREPACIFIC CORPORATION (KR) 2010-05-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113372-A1 Method For Preparing Kaempferol-3-0-Rutinoside and Composition of Skin External Application Comprising Thereof MGAM, CUTA, ENGASE P4HB 2911/4885POLB 1516/4885GAA 26/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback